| Term 
 
        | Pure Food & Drug Act (1906) |  | Definition 
 
        | Fed. gov. (FDA) may enforce standards of drug strength & purity as officially designated by the United States Pharmacopoeia (USP) & National Formulary (FP) Prohibits mislabeling & adulteration of drugs
 |  | 
        |  | 
        
        | Term 
 
        | Food, Drug, & Cosmetic Act (1938) |  | Definition 
 
        | Enforced by FDA through registration of all parties involved in manufacture, sale, & distribution of drugs Required adequate testing of a compound to prevent marketing of a possibly toxic substance. New drugs must be safe as well as pure in order to be introduced into interstate commerce
 Still does not require proof of effectiveness
 |  | 
        |  | 
        
        | Term 
 
        | Kefauver-Harris Amendments (1962) |  | Definition 
 
        | Required proof of efficacy as well as safety before any new drug could be placed in interstate commerce Guidelines for conducting clinical trials
 Established the Drug Efficacy Study Implementation (DESI)
 |  | 
        |  | 
        
        | Term 
 
        | L. Omnibus Budget Reconciliation Act of 1990 (OBRA '90 - amended many times) |  | Definition 
 
        | Amended 1965 Medicaid Law; implemented by the Health Care Financing Administration (HCFA) New regulations & requirements
 Participation of states in federal Medicaid program
 Development of drug utilization review (DUR)
 Patient counseling - pharmacist must offer counseling to patient. If patient refuses they sign paper admitting so
 |  | 
        |  | 
        
        | Term 
 
        | Food & Drug Administration Modernization Act (FDAMA) (1997) |  | Definition 
 
        | Allows for fast tracking of drugs for serious illnesses to market Drug manufacturers have to give patients 6 months notice before they discontinue making a drug
 Established clinical trial database for drugs for critical illnesses
 Informs of "off-label" uses (Erythromycin off-label use is stimulation of bowel movement)
 Incentives for pediatric drug research
 |  | 
        |  | 
        
        | Term 
 
        | Best Pharmaceuticals for Children Act (BPCA) (2002) & Pediatric Research Equity Act (2003) |  | Definition 
 
        | Both promote drug studies in children See how existing drugs work in children and determine safety
 Set up pediatric drug trials
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | High abuse potential & no accepted medical use in the US Investigational drugs - drug study
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Currently accepted medical use in US w/ high abuse potential resulting in severe physical or psychological dependence Written prescription required w/ prescribers actual, legal signature
 Must be dated same day as signed
 No refills allowed
 In emergency, verbal order may be given for limited quantity adequate to treat emergency, but must be followed by written prescription w/i 72 hrs. (However, not in AL --> state law)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Abuse potential less than schedule II (but more likely to be abused b/c less stringent rules) Written or verbal prescriptions allowed; valid for 6 months from date written
 Limit of 5 refills
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Abuse potential less than Schedule III, but same rules Written or verbal prescriptions allowed; valid for 6 months from date written
 limit of 5 refills
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lowest abuse potential Some drugs are non-legend both fed and state; purchase still subject to state regulations (ie: sudafed)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oral (peroral, po) Sublingual (sl) - tablets placed under tongue & allowed to dissolve; sometimes divided in 2, the 2nd being buccal (cheek)
 Rectal (pr)
 Capsules & tablets have rate limiting effects
 |  | 
        |  | 
        
        | Term 
 
        | Parenteral Route - Injectables |  | Definition 
 
        | Intravenous (iv) Intramuscular (im)
 Subcutaneous (sc; subQ)
 Requires sterile dosage forms
 Faster onset of action
 Skill & training required
 Used for drugs which do not undergo GI absorption, or which are unstable in GI tract
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1 hr before or 4 hr after eating. Usually just tell patients 2 hr before or after b/c hard to remember last time you ate |  | 
        |  | 
        
        | Term 
 
        | First Pass Effect (pre-systemic metabolism) |  | Definition 
 
        | During process of absorption from GI tract drug may be altered (metabolized) in 1)gut wall and 2)liver. If drug gets metabolized as it passes through either of these sites it will likely not be effective before reaching systemic circulation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Must be sterile Drops
 Ointment
 Disk insert
 Used for local effects, diagnosis, & treatment of eye disorders
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drops (solution, suspension) Contraindicated in perforated eardrum
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drops Sprays
 Used primarily for local effects (decongestants)
 May be used for systemic effects
 Nose can get "hooked on" nasal sprays; withdrawals include stuffyness
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Metered-dose inhaler (MDI) - nebulizer Intended for local effects
 Some systemic absorption may occur & cause side effects
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Creams, ointments, lotions, shampoos, transdermal systems (patches), May be used for either local or systemic effects (nitroglycerin ointments, patches..)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Study of how genetic variations affect individual responses to drugs Impacts therapeutic & adverse effects
 Clinically relevant for several drugs thus far, though testing is only required for a few
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Catalized by cytochrome P450 family in liver Induction (taking other drugs that increase activity of liver enzymes) & inhibition (taking other drugs that inhibit liver enzymes) are variables that can effect this step
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Gut wall & liver Usually can't do this phase first year of our lives
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Kidneys, bile (followed by fecal excretion), pulmonary, milk, saliva (swallowed, reabsorbed) Renal function approaches adult levels after about 1 yr
 Progressive decline in renal function as we age; resulting drug accumulation most common cause of ADRs in elderly
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | drug which interacts with a receptor to produce a pharmacologic response that is the same response produced by the endogenous compound Lock & key fit - binds just like chemical would High affinity & efficacy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | "blockers" Drug which interacts with receptor to block the actions of the endogenous agonist
 High affinity
 Zero efficacy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug which can interact with a receptor but produces a much weaker pharmacologic response than a full agonist These are sometimes used in pain management & anesthesia
 Low affinity & efficacy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Certain drugs & foreign chemicals stimulate the activity of drug metabolizing enzyme (P450) in the liver by inducing the synthesis of these enzymes. Net effect of induction is to increase metabolism of other drugs normally metabolized in the liver & to decrease pharmacological effects |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Certain drugs may inhibit the activity of drug metabolizing enzymes in liver. By interfering with metabolism of other drugs, inhibitors may increase or prolong activity of drugs normally metabolized  in liver. Effects occur over a few days to a week |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Unwanted effects that appear at normal doses required for therapeutic response Expected & normal with most drugs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Rare adverse drug response resulting from genetic predisposition Occurs w/ certain anesthetics
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Response where a drug causes a disease-like state Aspirin may cause gastritis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Unwanted effects that appear due to drug dosage that is increased beyond dose required for therapeutic response |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lethal dose 50 Dose which is lethal to 50% of test subjects
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Effective dose 50 Dose which produces desired therapeutic effect in 50% of test subjects
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ratio of LD50/ED50 - how safe drug is Lower than TI - more unsafe
 Higher than TI - more safe
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | May present as anaphylaxis with respiratory failure & shock Quick, unpredictable, can cause death
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Autoimmune reaction, like rash |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Seen w/ injectables, inflamed blood vessels |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Skin, like a reaction to a glove |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Usually induce or inhibit liver enzymes |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Due to charcoal, kaolin-pectin (present in anti-diarrheals), & aluminum or magnesium-containing antacids Activated charcoal is often put down an NG tube to bind to medicine so the body doesn't absorb it
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Formation of a non-absorbable complex that reduces drug absorption. Some drugs love Ca2+ (tetracycline) so you cannot eat any Ca2+ containing foods with it otherwise Ca2+ will complex w/ drug, often causing one to emesis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Combo of 2 drugs producing a pharmacologic effect which is sum of 2 individual drug effects (Acetominophine + hydrocodone) 1+1=2 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Combo of 2 drugs producing pharmacological effect that is greater than sum of 2 individual effects. 1+1=3 CNS depression by combining alcohol & barbiturates
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Combined effect is less than effect produced by active drug alone. 2nd drug cancels out 1st. 1+1=0 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Directions to patient; transcribed by pharmacist onto label of dispensed medication |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adherence to a recommended course of treatment |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Right patient, route, dose, time, drug, & to refuse |  | 
        |  |